Screener
AtriCure ATRC EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AtriCure in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: AtriCure’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 1:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001323885-26-000035
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $8,955 | $(6,190) | $9,063 | $(12,937) |
| Net income (loss) per share | ||||
| Basic net income (loss) per share | $0.18 | $(0.13) | $0.19 | $(0.27) |
| Diluted net income (loss) per share | $0.18 | $(0.13) | $0.18 | $(0.27) |
| Weighted average shares outstanding | ||||
| Basic | 48,667 | 47,721 | 48,501 | 47,557 |
| Diluted | 48,868 | 47,721 | 49,094 | 47,557 |
| Comprehensive income (loss): |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is AtriCure's EPS (diluted)?
- AtriCure (ATRC) reported EPS (diluted) of $0.18 in Q2 2026.
- How has AtriCure's EPS (diluted) changed year-over-year?
- AtriCure's EPS (diluted) increased by 238.5% year-over-year, from -$0.13 to $0.18.
- What is the long-term trend for AtriCure's EPS (diluted)?
- Over 2 years (2022 to 2024), AtriCure's EPS (diluted) has grown at a -3.0% compound annual growth rate (CAGR), from -$1.01 to -$0.95.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about AtriCure's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude